Topic: Sativex

Chicago Mayor Rahm Emanuel has moved to decriminalize small amounts of marijuana, a shift that coincides with Big Pharma's development of synthetic cannabinoids like Sativex. The discussion posits that the government is clearing out street competition and synthetic "bath salts" to pave the way for pharmaceutical companies to dominate a legal, patented marijuana market.

GW Pharmaceuticals is bringing Sativex, a liquid cannabinoid medicine, to market. The discussion suggests that the current crackdown on independent medical marijuana dispensaries is a coordinated effort to transition the industry into the hands of approved pharmaceutical dealers. This shift is viewed as a financial strategy to benefit corporate interests and political donors.